What is the role of disintegration and dissolution testing in tablet quality control?

• A. Disintegration ensures tablets break into smaller fragments before dissolution; dissolution determines the rate and extent of drug release, correlating with bioavailability and batch-to-batch consistency.
• B. Disintegration testing alone is sufficient for predicting patient response.
• C. Dissolution testing has no relation to bioavailability.
• D. Both tests are unnecessary for quality control.

Answer: (A)

Disintegration and dissolution testing in tablet quality control ensure the tablet will behave predictably in the body. Disintegration assesses how readily a tablet breaks into smaller pieces once it’s in the GI environment; this breakup is a prerequisite for drug release. Dissolution then measures the rate and extent to which the drug goes into solution under simulated GI conditions, which is the step that determines how much drug becomes available for absorption. Because the rate and extent of dissolution influence bioavailability, dissolution testing provides an indicator of how a batch will perform in patients, while disintegration testing helps catch issues that would prevent timely breakup. Together, they connect the tablet’s physical integrity to its chemical release, supporting batch-to-batch consistency and overall quality control. The other statements don’t fit because disintegration alone doesn’t predict patient response, dissolution is related to bioavailability, and these tests are standard QC tools, not optional.